At the heart of the OmniAb Technology Stack is the Biological Intelligence™ (BI) of our proprietary and validated transgenic animals, including OmniRat®, OmniChicken® and OmniMouse®, each capable of generating high quality fully human antibodies that have been optimized naturally through in vivo affinity maturation. OmniFlic® (transgenic rat) and OmniClic™ (transgenic chicken) address industry needs for bispecific antibody applications through a common light chain approach, and OmniTaur™ features unique structural attributes of cow antibodies for complex targets. Our transgenic animals comprise the most diverse host systems available in the industry and they are optimally leveraged within the OmniAb Technology Stack through AI-enhanced antigen design and immunization methods, paired with high-throughput and microfluidic-based single B cell screening and deep computational analysis of next-generation sequencing datasets to identify fully human antibodies with superior performance and developability characteristics. The OmniAb stack of technologies and differentiating AI and BI features have been combined to offer a highly efficient, scalable and customizable solution for the growing antibody discovery needs of the global biopharmaceutical industry.
Learn more at www.omniab.com